averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EBF1
|
ENSG00000164330.12 | EBF transcription factor 1 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23229960 | 64.30 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr16_+_222846 | 61.81 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr17_+_38083977 | 45.09 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr11_-_111781454 | 43.57 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr11_-_111794446 | 43.44 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr14_-_21270995 | 42.96 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_-_156217875 | 42.33 |
ENST00000292291.5
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr5_-_149792295 | 40.13 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr1_+_6845384 | 39.80 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr1_-_156217822 | 39.36 |
ENST00000368270.1
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr4_-_57522673 | 38.87 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr22_+_23101182 | 38.52 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr2_+_17935383 | 38.41 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr1_-_156217829 | 38.38 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
chr11_-_111781610 | 37.98 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr4_-_5891918 | 36.64 |
ENST00000512574.1
|
CRMP1
|
collapsin response mediator protein 1 |
chr4_-_57522598 | 36.03 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr11_-_111781554 | 35.34 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr14_+_22984601 | 33.45 |
ENST00000390509.1
|
TRAJ28
|
T cell receptor alpha joining 28 |
chr2_+_17935119 | 32.96 |
ENST00000317402.7
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr12_+_10365404 | 32.46 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr19_-_38720294 | 31.37 |
ENST00000412732.1
ENST00000456296.1 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
chr19_-_37019562 | 30.95 |
ENST00000523638.1
|
ZNF260
|
zinc finger protein 260 |
chr2_-_176866978 | 30.92 |
ENST00000392540.2
ENST00000409660.1 ENST00000544803.1 ENST00000272748.4 |
KIAA1715
|
KIAA1715 |
chr13_-_30881621 | 30.86 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr11_-_117748138 | 30.38 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr19_-_37019136 | 30.00 |
ENST00000592282.1
|
ZNF260
|
zinc finger protein 260 |
chr5_-_42825983 | 29.96 |
ENST00000506577.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr19_+_35630628 | 29.30 |
ENST00000588715.1
ENST00000588607.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr1_+_152635854 | 28.31 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr19_+_49622646 | 27.68 |
ENST00000334186.4
|
PPFIA3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
chr14_-_21270561 | 27.44 |
ENST00000412779.2
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_-_156390128 | 26.21 |
ENST00000368242.3
|
C1orf61
|
chromosome 1 open reading frame 61 |
chr7_+_24323782 | 26.19 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
chr8_-_70983506 | 26.08 |
ENST00000276594.2
|
PRDM14
|
PR domain containing 14 |
chr8_-_22089533 | 26.03 |
ENST00000321613.3
|
PHYHIP
|
phytanoyl-CoA 2-hydroxylase interacting protein |
chr3_-_58563094 | 25.99 |
ENST00000464064.1
|
FAM107A
|
family with sequence similarity 107, member A |
chr8_+_136470270 | 25.95 |
ENST00000524199.1
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
chr22_+_23165153 | 25.53 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr12_+_53443963 | 25.44 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr19_-_38720354 | 25.29 |
ENST00000416611.1
|
DPF1
|
D4, zinc and double PHD fingers family 1 |
chr6_+_33043703 | 25.19 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr12_+_53443680 | 24.69 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr1_+_2005425 | 23.69 |
ENST00000461106.2
|
PRKCZ
|
protein kinase C, zeta |
chr19_+_35630926 | 23.68 |
ENST00000588081.1
ENST00000589121.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr6_-_31514333 | 23.48 |
ENST00000376151.4
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr6_-_46459099 | 23.37 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr4_+_4388805 | 23.34 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr22_-_19512893 | 23.16 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
chr1_-_20812690 | 23.15 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr1_+_44115814 | 22.56 |
ENST00000372396.3
|
KDM4A
|
lysine (K)-specific demethylase 4A |
chr10_+_106034884 | 22.41 |
ENST00000369707.2
ENST00000429569.2 |
GSTO2
|
glutathione S-transferase omega 2 |
chr8_+_21911054 | 22.36 |
ENST00000519850.1
ENST00000381470.3 |
DMTN
|
dematin actin binding protein |
chr16_-_21289627 | 22.34 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
chr19_+_50706866 | 21.67 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
chr19_+_17326141 | 21.56 |
ENST00000445667.2
ENST00000263897.5 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr19_+_17326521 | 21.35 |
ENST00000593597.1
|
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr10_+_101089107 | 21.35 |
ENST00000446890.1
ENST00000370528.3 |
CNNM1
|
cyclin M1 |
chr11_+_121447469 | 21.33 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr12_-_123215306 | 21.21 |
ENST00000356987.2
ENST00000436083.2 |
HCAR1
|
hydroxycarboxylic acid receptor 1 |
chr19_+_50380917 | 21.17 |
ENST00000535102.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr14_+_95078714 | 21.11 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr4_-_681114 | 21.07 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
chr19_-_49945617 | 20.99 |
ENST00000600601.1
ENST00000543531.1 |
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr1_+_35225339 | 20.97 |
ENST00000339480.1
|
GJB4
|
gap junction protein, beta 4, 30.3kDa |
chr12_-_71182695 | 20.94 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr14_+_73704201 | 20.93 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
chr19_+_17326191 | 20.87 |
ENST00000595101.1
ENST00000596136.1 ENST00000379776.4 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr14_-_106174960 | 20.83 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr14_-_21493884 | 20.54 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr8_-_144241664 | 20.46 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr4_+_156588350 | 20.44 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr1_-_11866034 | 20.20 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr15_+_44580899 | 20.13 |
ENST00000559222.1
ENST00000299957.6 |
CASC4
|
cancer susceptibility candidate 4 |
chr16_-_70472946 | 20.02 |
ENST00000342907.2
|
ST3GAL2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
chr19_-_49137790 | 19.93 |
ENST00000599385.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr8_-_144242020 | 19.92 |
ENST00000414417.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr4_+_2965307 | 19.69 |
ENST00000398051.4
ENST00000503518.2 ENST00000398052.4 ENST00000345167.6 ENST00000504933.1 ENST00000442472.2 |
GRK4
|
G protein-coupled receptor kinase 4 |
chr20_+_44657845 | 19.57 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr5_+_156712372 | 19.51 |
ENST00000541131.1
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr22_+_23134974 | 19.50 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr8_-_98290087 | 19.49 |
ENST00000322128.3
|
TSPYL5
|
TSPY-like 5 |
chr14_-_106054659 | 19.45 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr4_+_128554081 | 19.36 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
chr17_-_43045439 | 19.36 |
ENST00000253407.3
|
C1QL1
|
complement component 1, q subcomponent-like 1 |
chr16_+_10479906 | 19.32 |
ENST00000562527.1
ENST00000396560.2 ENST00000396559.1 ENST00000562102.1 ENST00000543967.1 ENST00000569939.1 ENST00000569900.1 |
ATF7IP2
|
activating transcription factor 7 interacting protein 2 |
chr8_+_28747884 | 19.30 |
ENST00000287701.10
ENST00000444075.1 ENST00000403668.2 ENST00000519662.1 ENST00000558662.1 ENST00000523613.1 ENST00000560599.1 ENST00000397358.3 |
HMBOX1
|
homeobox containing 1 |
chr4_-_57522470 | 19.17 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
chr4_-_186877502 | 19.12 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr16_+_28834303 | 18.89 |
ENST00000340394.8
ENST00000325215.6 ENST00000395547.2 ENST00000336783.4 ENST00000382686.4 ENST00000564304.1 |
ATXN2L
|
ataxin 2-like |
chr22_-_45559642 | 18.79 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
chr14_-_21493649 | 18.73 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
chr1_+_22964073 | 18.60 |
ENST00000402322.1
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr1_-_161519579 | 18.54 |
ENST00000426740.1
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr1_-_161279749 | 18.47 |
ENST00000533357.1
ENST00000360451.6 ENST00000336559.4 |
MPZ
|
myelin protein zero |
chr9_-_86571628 | 18.46 |
ENST00000376344.3
|
C9orf64
|
chromosome 9 open reading frame 64 |
chr3_+_49027308 | 18.46 |
ENST00000383729.4
ENST00000343546.4 |
P4HTM
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
chr15_+_44580955 | 18.42 |
ENST00000345795.2
ENST00000360824.3 |
CASC4
|
cancer susceptibility candidate 4 |
chr11_+_117063295 | 18.37 |
ENST00000525478.1
ENST00000532062.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr7_+_65338230 | 18.09 |
ENST00000360768.3
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr12_+_21679220 | 18.07 |
ENST00000256969.2
|
C12orf39
|
chromosome 12 open reading frame 39 |
chr8_-_80680078 | 18.04 |
ENST00000337919.5
ENST00000354724.3 |
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
chr9_-_98079965 | 17.98 |
ENST00000289081.3
|
FANCC
|
Fanconi anemia, complementation group C |
chr20_-_4804244 | 17.98 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr14_+_24630465 | 17.93 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr19_-_49137762 | 17.92 |
ENST00000593500.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr5_-_138725560 | 17.76 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr1_-_161519682 | 17.68 |
ENST00000367969.3
ENST00000443193.1 |
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr3_-_49907323 | 17.67 |
ENST00000296471.7
ENST00000488336.1 ENST00000467248.1 ENST00000466940.1 ENST00000463537.1 ENST00000480398.2 |
CAMKV
|
CaM kinase-like vesicle-associated |
chr3_-_38071122 | 17.66 |
ENST00000334661.4
|
PLCD1
|
phospholipase C, delta 1 |
chr22_+_23040274 | 17.65 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr20_+_42143136 | 17.57 |
ENST00000373134.1
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila) |
chr1_+_1981890 | 17.57 |
ENST00000378567.3
ENST00000468310.1 |
PRKCZ
|
protein kinase C, zeta |
chr1_+_160097462 | 17.50 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr7_+_102715315 | 17.47 |
ENST00000428183.2
ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10
|
armadillo repeat containing 10 |
chr15_+_41136586 | 17.23 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr5_-_138725594 | 17.16 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chr12_-_89919965 | 17.12 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
chr1_-_213031418 | 17.00 |
ENST00000356684.3
ENST00000426161.1 ENST00000424044.1 |
FLVCR1-AS1
|
FLVCR1 antisense RNA 1 (head to head) |
chr1_+_150229554 | 16.93 |
ENST00000369111.4
|
CA14
|
carbonic anhydrase XIV |
chr17_+_43972010 | 16.80 |
ENST00000334239.8
ENST00000446361.3 |
MAPT
|
microtubule-associated protein tau |
chr16_+_30662360 | 16.72 |
ENST00000542965.2
|
PRR14
|
proline rich 14 |
chr1_-_203320617 | 16.66 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
chr16_-_30102547 | 16.65 |
ENST00000279386.2
|
TBX6
|
T-box 6 |
chr19_-_3028354 | 16.56 |
ENST00000586422.1
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chr5_+_148786423 | 16.54 |
ENST00000505254.2
ENST00000602964.1 ENST00000519898.1 |
MIR143HG
|
MIR143 host gene (non-protein coding) |
chr20_+_42143053 | 16.52 |
ENST00000373135.3
ENST00000444063.1 |
L3MBTL1
|
l(3)mbt-like 1 (Drosophila) |
chr16_+_1583567 | 16.52 |
ENST00000566264.1
|
TMEM204
|
transmembrane protein 204 |
chr22_+_29138013 | 16.47 |
ENST00000216027.3
ENST00000398941.2 |
HSCB
|
HscB mitochondrial iron-sulfur cluster co-chaperone |
chr2_+_89986318 | 16.47 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr1_+_151254738 | 16.47 |
ENST00000336715.6
ENST00000324048.5 ENST00000368879.2 |
ZNF687
|
zinc finger protein 687 |
chr2_-_71454185 | 16.21 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr12_-_50290839 | 16.17 |
ENST00000552863.1
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr6_-_90025011 | 16.17 |
ENST00000402938.3
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
chr7_-_137028534 | 16.16 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
chr4_-_17812309 | 16.13 |
ENST00000382247.1
ENST00000536863.1 |
DCAF16
|
DDB1 and CUL4 associated factor 16 |
chr19_+_16435625 | 16.13 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr14_-_21493123 | 16.13 |
ENST00000556147.1
ENST00000554489.1 ENST00000555657.1 ENST00000557274.1 ENST00000555158.1 ENST00000554833.1 ENST00000555384.1 ENST00000556420.1 ENST00000554893.1 ENST00000553503.1 ENST00000555733.1 ENST00000553867.1 ENST00000397856.3 ENST00000397855.3 ENST00000556008.1 ENST00000557182.1 ENST00000554483.1 ENST00000556688.1 ENST00000397853.3 ENST00000556329.2 ENST00000554143.1 ENST00000397851.2 ENST00000555142.1 ENST00000557676.1 ENST00000556924.1 |
NDRG2
|
NDRG family member 2 |
chr8_+_144816303 | 16.10 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
chr17_-_18585541 | 16.06 |
ENST00000285274.5
ENST00000545289.1 ENST00000580145.1 |
ZNF286B
|
zinc finger protein 286B |
chr3_+_38347427 | 16.03 |
ENST00000273173.4
|
SLC22A14
|
solute carrier family 22, member 14 |
chr3_+_111717511 | 16.03 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr19_-_54872556 | 16.00 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr6_-_28367510 | 15.99 |
ENST00000361028.1
|
ZSCAN12
|
zinc finger and SCAN domain containing 12 |
chr17_+_8339164 | 15.93 |
ENST00000582665.1
ENST00000334527.7 ENST00000299734.7 |
NDEL1
|
nudE neurodevelopment protein 1-like 1 |
chr11_-_132813566 | 15.93 |
ENST00000331898.7
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
chr10_+_101088836 | 15.88 |
ENST00000356713.4
|
CNNM1
|
cyclin M1 |
chr1_-_21995794 | 15.85 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr19_+_2867325 | 15.80 |
ENST00000307635.2
ENST00000586426.1 |
ZNF556
|
zinc finger protein 556 |
chr15_-_83378611 | 15.74 |
ENST00000542200.1
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
chr8_-_19459993 | 15.71 |
ENST00000454498.2
ENST00000520003.1 |
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
chr19_+_50381308 | 15.70 |
ENST00000599049.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr5_+_74807886 | 15.62 |
ENST00000514296.1
|
POLK
|
polymerase (DNA directed) kappa |
chr19_-_4454081 | 15.61 |
ENST00000591919.1
|
UBXN6
|
UBX domain protein 6 |
chr1_+_45805728 | 15.60 |
ENST00000539779.1
|
TOE1
|
target of EGR1, member 1 (nuclear) |
chr20_+_61436146 | 15.60 |
ENST00000290291.6
|
OGFR
|
opioid growth factor receptor |
chr14_-_101036119 | 15.49 |
ENST00000355173.2
|
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr17_+_43971643 | 15.38 |
ENST00000344290.5
ENST00000262410.5 ENST00000351559.5 ENST00000340799.5 ENST00000535772.1 ENST00000347967.5 |
MAPT
|
microtubule-associated protein tau |
chr14_-_101034407 | 15.26 |
ENST00000443071.2
ENST00000557378.1 |
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr8_-_27469196 | 15.23 |
ENST00000546343.1
ENST00000560566.1 |
CLU
|
clusterin |
chr17_-_79105734 | 15.18 |
ENST00000417379.1
|
AATK
|
apoptosis-associated tyrosine kinase |
chr7_+_24324726 | 15.16 |
ENST00000405982.1
|
NPY
|
neuropeptide Y |
chr17_-_62009702 | 15.15 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr12_+_57522258 | 15.04 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr17_-_46507567 | 15.03 |
ENST00000584924.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
chr11_+_43380459 | 14.98 |
ENST00000299240.6
ENST00000039989.4 |
TTC17
|
tetratricopeptide repeat domain 17 |
chr12_+_1100370 | 14.98 |
ENST00000543086.3
ENST00000546231.2 ENST00000397203.2 |
ERC1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr19_-_45826125 | 14.95 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
chr20_+_1246908 | 14.94 |
ENST00000381873.3
ENST00000381867.1 |
SNPH
|
syntaphilin |
chr11_+_65479702 | 14.88 |
ENST00000530446.1
ENST00000534104.1 ENST00000530605.1 ENST00000528198.1 ENST00000531880.1 ENST00000534650.1 |
KAT5
|
K(lysine) acetyltransferase 5 |
chr8_-_144241432 | 14.86 |
ENST00000430474.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr10_+_104474207 | 14.82 |
ENST00000602831.1
ENST00000369893.5 |
SFXN2
|
sideroflexin 2 |
chr19_-_57183114 | 14.79 |
ENST00000537055.2
ENST00000601659.1 |
ZNF835
|
zinc finger protein 835 |
chrX_+_128913906 | 14.77 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr1_-_113162040 | 14.71 |
ENST00000358039.4
ENST00000369668.2 |
ST7L
|
suppression of tumorigenicity 7 like |
chr9_+_130965651 | 14.69 |
ENST00000475805.1
ENST00000341179.7 ENST00000372923.3 |
DNM1
|
dynamin 1 |
chr4_+_8594435 | 14.64 |
ENST00000382480.2
|
CPZ
|
carboxypeptidase Z |
chr19_-_7939319 | 14.62 |
ENST00000539422.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
chr10_+_76586348 | 14.58 |
ENST00000372724.1
ENST00000287239.4 ENST00000372714.1 |
KAT6B
|
K(lysine) acetyltransferase 6B |
chr1_+_27114589 | 14.58 |
ENST00000431541.1
ENST00000449950.2 ENST00000374145.1 |
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V |
chr10_-_90751038 | 14.56 |
ENST00000458159.1
ENST00000415557.1 ENST00000458208.1 |
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr11_+_17741111 | 14.55 |
ENST00000250003.3
|
MYOD1
|
myogenic differentiation 1 |
chr1_+_33352036 | 14.54 |
ENST00000373467.3
|
HPCA
|
hippocalcin |
chr11_+_73019282 | 14.53 |
ENST00000263674.3
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
chr10_-_71176623 | 14.46 |
ENST00000373306.4
|
TACR2
|
tachykinin receptor 2 |
chr17_-_62009621 | 14.42 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr22_-_37213554 | 14.35 |
ENST00000443735.1
|
PVALB
|
parvalbumin |
chr19_+_2977444 | 14.34 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
chr6_-_46293378 | 14.34 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chr12_-_51717948 | 14.33 |
ENST00000267012.4
|
BIN2
|
bridging integrator 2 |
chr9_+_130965677 | 14.26 |
ENST00000393594.3
ENST00000486160.1 |
DNM1
|
dynamin 1 |
chr17_-_56606705 | 14.24 |
ENST00000317268.3
|
SEPT4
|
septin 4 |
chr14_-_22005062 | 14.20 |
ENST00000317492.5
|
SALL2
|
spalt-like transcription factor 2 |
chr1_+_213123976 | 14.07 |
ENST00000366965.2
ENST00000366967.2 |
VASH2
|
vasohibin 2 |
chr6_-_46459675 | 14.03 |
ENST00000306764.7
|
RCAN2
|
regulator of calcineurin 2 |
chr17_-_40333099 | 14.03 |
ENST00000607371.1
|
KCNH4
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
chr2_-_24583314 | 14.01 |
ENST00000443927.1
ENST00000406921.3 ENST00000412011.1 |
ITSN2
|
intersectin 2 |
chr2_+_233497931 | 14.00 |
ENST00000264059.3
|
EFHD1
|
EF-hand domain family, member D1 |
chr6_-_90024967 | 13.99 |
ENST00000602399.1
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
chr1_-_45805752 | 13.97 |
ENST00000354383.6
ENST00000355498.2 ENST00000372100.5 ENST00000531105.1 |
MUTYH
|
mutY homolog |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.8 | 71.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
12.9 | 38.7 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
12.2 | 36.6 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
11.8 | 70.6 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
10.3 | 51.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
9.8 | 78.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
9.6 | 28.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
8.7 | 156.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
8.7 | 26.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
8.7 | 26.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
8.5 | 25.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
8.5 | 42.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
8.4 | 25.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
8.4 | 25.1 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
7.9 | 15.9 | GO:0045214 | sarcomere organization(GO:0045214) |
7.8 | 54.4 | GO:0045007 | depurination(GO:0045007) |
7.6 | 37.9 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
7.2 | 14.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
7.2 | 28.9 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
7.1 | 21.3 | GO:1902769 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
7.0 | 34.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
6.9 | 41.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
6.8 | 34.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
6.6 | 6.6 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
6.5 | 19.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
6.4 | 19.3 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
6.4 | 19.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
6.4 | 6.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
6.2 | 24.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
5.9 | 41.3 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
5.8 | 17.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
5.4 | 21.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
5.4 | 16.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
5.3 | 16.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
5.3 | 31.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
5.3 | 15.9 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
5.1 | 30.9 | GO:0051013 | microtubule severing(GO:0051013) |
5.1 | 15.3 | GO:0009447 | putrescine catabolic process(GO:0009447) |
5.0 | 15.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
5.0 | 25.0 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
4.9 | 19.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
4.8 | 19.4 | GO:0061743 | motor learning(GO:0061743) |
4.8 | 14.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
4.6 | 18.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
4.6 | 32.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
4.6 | 105.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
4.6 | 13.7 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
4.5 | 18.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
4.4 | 26.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
4.4 | 13.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
4.4 | 43.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
4.3 | 12.9 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
4.3 | 25.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
4.2 | 12.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
4.2 | 20.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.1 | 4.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
4.1 | 16.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
4.1 | 12.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
4.1 | 12.2 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
4.0 | 44.5 | GO:0033227 | dsRNA transport(GO:0033227) |
4.0 | 20.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
4.0 | 16.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
4.0 | 12.0 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
3.9 | 31.5 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
3.9 | 15.7 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
3.9 | 7.9 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
3.9 | 15.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
3.9 | 15.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
3.9 | 11.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
3.8 | 11.5 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
3.8 | 26.8 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
3.8 | 11.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
3.8 | 30.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.8 | 26.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
3.8 | 15.1 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
3.7 | 22.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.7 | 14.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
3.7 | 3.7 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
3.7 | 11.2 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
3.7 | 11.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
3.7 | 18.5 | GO:0035106 | operant conditioning(GO:0035106) |
3.6 | 14.5 | GO:1902075 | cellular response to salt(GO:1902075) |
3.6 | 32.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
3.6 | 10.8 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
3.6 | 3.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
3.6 | 14.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
3.5 | 10.6 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
3.5 | 14.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.5 | 10.5 | GO:0030239 | myofibril assembly(GO:0030239) |
3.4 | 6.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.4 | 20.4 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
3.4 | 10.1 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
3.4 | 23.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
3.4 | 53.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.3 | 6.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
3.3 | 10.0 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
3.2 | 39.0 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
3.2 | 3.2 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
3.2 | 19.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
3.2 | 28.9 | GO:0006477 | protein sulfation(GO:0006477) |
3.2 | 15.9 | GO:0033590 | response to cobalamin(GO:0033590) |
3.2 | 9.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
3.2 | 9.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
3.2 | 9.5 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
3.1 | 9.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
3.1 | 12.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
3.1 | 12.3 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
3.1 | 15.3 | GO:1903971 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
3.0 | 8.9 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
3.0 | 8.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
3.0 | 11.8 | GO:0021633 | optic nerve structural organization(GO:0021633) |
2.9 | 8.8 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
2.9 | 17.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.9 | 8.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
2.9 | 23.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
2.9 | 14.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
2.9 | 5.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.9 | 8.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.9 | 8.6 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
2.8 | 5.7 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
2.8 | 11.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
2.8 | 25.5 | GO:0042048 | olfactory behavior(GO:0042048) |
2.8 | 22.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
2.8 | 8.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.8 | 8.3 | GO:0044805 | late nucleophagy(GO:0044805) |
2.8 | 16.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
2.8 | 2.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
2.8 | 13.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.8 | 8.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
2.8 | 16.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.7 | 10.9 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
2.7 | 8.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
2.7 | 16.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.7 | 13.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
2.6 | 26.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.6 | 21.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
2.6 | 10.5 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
2.6 | 28.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
2.6 | 5.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.6 | 10.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
2.6 | 2.6 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
2.6 | 28.1 | GO:0099638 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) endosome to plasma membrane protein transport(GO:0099638) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
2.6 | 10.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
2.5 | 10.0 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
2.5 | 7.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
2.5 | 9.9 | GO:0003335 | corneocyte development(GO:0003335) |
2.5 | 24.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.4 | 9.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
2.4 | 22.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.4 | 19.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.4 | 12.2 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
2.4 | 4.9 | GO:0032571 | response to vitamin K(GO:0032571) |
2.4 | 338.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.4 | 9.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
2.4 | 7.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
2.4 | 4.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.4 | 4.8 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
2.4 | 7.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
2.4 | 7.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
2.4 | 26.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.4 | 9.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.4 | 7.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.3 | 11.7 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
2.3 | 7.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) establishment of meiotic spindle localization(GO:0051295) |
2.3 | 27.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.3 | 11.6 | GO:0097017 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) renal protein absorption(GO:0097017) protein processing in phagocytic vesicle(GO:1900756) regulation of plasma membrane raft polarization(GO:1903906) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
2.3 | 6.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
2.3 | 27.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.3 | 16.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.3 | 6.9 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
2.3 | 36.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
2.3 | 13.6 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.3 | 11.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.3 | 9.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.3 | 4.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
2.2 | 6.7 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
2.2 | 6.7 | GO:0015793 | glycerol transport(GO:0015793) |
2.2 | 6.7 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
2.2 | 35.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.2 | 24.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
2.2 | 2.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
2.2 | 10.9 | GO:0046968 | peptide antigen transport(GO:0046968) |
2.2 | 6.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
2.2 | 6.5 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.2 | 17.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.2 | 15.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.1 | 15.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.1 | 6.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
2.1 | 8.5 | GO:0002215 | defense response to nematode(GO:0002215) |
2.1 | 2.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
2.1 | 8.4 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.1 | 10.4 | GO:0016322 | neuron remodeling(GO:0016322) |
2.1 | 14.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
2.1 | 60.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
2.1 | 29.0 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
2.1 | 30.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.0 | 6.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
2.0 | 21.9 | GO:0045008 | depyrimidination(GO:0045008) |
2.0 | 8.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
2.0 | 25.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
2.0 | 3.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
2.0 | 5.9 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
2.0 | 15.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.9 | 11.6 | GO:0018343 | protein farnesylation(GO:0018343) |
1.9 | 21.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.9 | 1.9 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.9 | 5.7 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
1.9 | 126.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.9 | 22.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.8 | 7.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.8 | 7.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.8 | 23.9 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.8 | 7.3 | GO:0007525 | somatic muscle development(GO:0007525) |
1.8 | 7.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.8 | 18.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.8 | 14.5 | GO:0001675 | acrosome assembly(GO:0001675) |
1.8 | 5.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.8 | 19.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
1.8 | 5.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.8 | 7.0 | GO:0032782 | bile acid secretion(GO:0032782) |
1.7 | 8.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.7 | 5.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.7 | 8.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.7 | 17.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.7 | 12.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.7 | 3.4 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.7 | 10.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.7 | 5.0 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
1.7 | 3.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
1.7 | 6.7 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
1.7 | 8.3 | GO:0001501 | skeletal system development(GO:0001501) |
1.7 | 6.6 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.7 | 9.9 | GO:0032418 | lysosome localization(GO:0032418) |
1.7 | 6.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.7 | 1.7 | GO:0060433 | bronchus development(GO:0060433) |
1.6 | 1.6 | GO:0043366 | beta selection(GO:0043366) |
1.6 | 4.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.6 | 6.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
1.6 | 8.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.6 | 41.9 | GO:0097503 | sialylation(GO:0097503) |
1.6 | 4.8 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
1.6 | 23.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.6 | 22.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.6 | 7.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.6 | 4.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
1.6 | 6.3 | GO:0035640 | exploration behavior(GO:0035640) |
1.6 | 4.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.5 | 4.6 | GO:0021938 | ventral midline development(GO:0007418) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.5 | 13.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
1.5 | 15.0 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
1.5 | 7.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.5 | 3.0 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
1.5 | 4.5 | GO:0003160 | endocardium morphogenesis(GO:0003160) stem cell fate commitment(GO:0048865) endocardium formation(GO:0060214) |
1.5 | 42.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
1.5 | 7.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.5 | 7.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.5 | 17.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.5 | 2.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
1.5 | 2.9 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.5 | 11.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.5 | 2.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.4 | 50.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.4 | 4.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.4 | 21.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.4 | 2.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.4 | 15.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.4 | 9.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.4 | 12.7 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
1.4 | 22.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.4 | 5.6 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.4 | 7.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.4 | 8.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.4 | 2.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.4 | 8.3 | GO:1903301 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
1.4 | 15.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.4 | 6.9 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.4 | 17.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.4 | 34.1 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.4 | 2.7 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
1.4 | 8.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.4 | 17.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.4 | 6.8 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
1.4 | 21.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
1.4 | 2.7 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
1.4 | 19.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
1.3 | 14.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.3 | 4.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
1.3 | 10.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.3 | 1.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
1.3 | 29.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.3 | 4.0 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) sebaceous gland development(GO:0048733) formation of anatomical boundary(GO:0048859) cell proliferation involved in heart valve development(GO:2000793) |
1.3 | 5.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.3 | 10.5 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.3 | 11.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.3 | 3.9 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
1.3 | 3.9 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.3 | 11.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
1.3 | 7.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.3 | 41.1 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
1.3 | 9.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
1.3 | 5.1 | GO:0015942 | folic acid-containing compound catabolic process(GO:0009397) formate metabolic process(GO:0015942) pteridine-containing compound catabolic process(GO:0042560) |
1.3 | 21.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
1.3 | 5.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.2 | 20.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
1.2 | 12.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.2 | 15.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 5.0 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
1.2 | 28.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.2 | 7.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
1.2 | 2.4 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
1.2 | 3.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.2 | 4.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.2 | 19.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
1.2 | 8.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.2 | 3.6 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.2 | 6.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.2 | 3.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 3.6 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
1.2 | 23.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
1.2 | 3.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
1.2 | 8.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
1.2 | 37.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.2 | 14.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
1.2 | 5.8 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
1.2 | 10.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
1.2 | 13.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.2 | 2.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.2 | 9.2 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
1.1 | 4.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.1 | 11.4 | GO:0006473 | protein acetylation(GO:0006473) |
1.1 | 3.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.1 | 5.7 | GO:0030035 | microspike assembly(GO:0030035) |
1.1 | 3.4 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.1 | 6.8 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
1.1 | 1.1 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
1.1 | 6.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.1 | 3.4 | GO:1904300 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.1 | 5.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 2.2 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
1.1 | 3.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.1 | 4.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.1 | 3.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.1 | 3.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.1 | 2.2 | GO:1900158 | negative regulation of osteoclast proliferation(GO:0090291) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
1.1 | 10.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.1 | 12.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
1.1 | 6.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 14.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.1 | 3.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.1 | 19.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
1.1 | 5.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.1 | 45.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 9.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
1.1 | 7.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.1 | 8.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 5.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
1.1 | 4.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.1 | 3.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.1 | 4.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 21.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 3.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.0 | 11.5 | GO:0021988 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
1.0 | 20.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.0 | 7.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
1.0 | 3.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
1.0 | 26.8 | GO:0071800 | podosome assembly(GO:0071800) |
1.0 | 7.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
1.0 | 10.2 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 10.1 | GO:0001759 | organ induction(GO:0001759) |
1.0 | 8.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.0 | 3.0 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
1.0 | 7.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.0 | 44.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.0 | 4.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.0 | 8.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) nucleoside triphosphate catabolic process(GO:0009143) |
1.0 | 12.6 |